Cargando…

Targeting Low HDL-Cholesterol to Decrease Residual Cardiovascular Risk in the Managed Care Setting

BACKGROUND: Most clinicians recognize the importance of reducinglow-density lipoprotein cholesterol (LDL-C) and, therefore, address thistherapeutic need to decrease cardiovascular disease risk. In addition to thecritical role that LDL-C plays, recent studies have shown the contribution ofother lipid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cziraky, Mark J., Watson, Karol E., Talbert, Robert L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2008
Materias:	Supplement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438150/ https://www.ncbi.nlm.nih.gov/pubmed/18950252 http://dx.doi.org/10.18553/jmcp.2008.14.S8-A.1

Ejemplares similares

Maintaining Cardiovascular Health in Patients With Mixed Dyslipidemia Optimizing the Management of Hypertriglyceridemia and Non-HDL Cholesterol
por: Ito, Matthew, et al.
Publicado: (2009)

Beyond LDL-Cholesterol: The Role of Low HDL-Cholesterol and Elevated TG in Residual Cardiovascular Risk Remaining After Statin Therapy
por: Watson, Karol E.
Publicado: (2008)

The Impact of Residual Cardiovascular Risk in Combination Lipid-Modifying Therapy in the Managed Care Setting
por: Talbert, Robert L.
Publicado: (2008)

Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk
por: Bergmann, Katarzyna
Publicado: (2010)

HDL Size is More Accurate than HDL Cholesterol to Predict Carotid Subclinical Atherosclerosis in Individuals Classified as Low Cardiovascular Risk
por: Parra, Eliane Soler, et al.
Publicado: (2014)

Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol: a cohort study
por: Hansen, Malene Kærslund, et al.
Publicado: (2023)

HIGHER HDL CHOLESTEROL LEVELS DECREASE SUSCEPTIBILITY TO COVID-19 INFECTION
por: Chidambaram, Vignesh, et al.
Publicado: (2023)

Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population
por: Nantsupawat, Nopakoon, et al.
Publicado: (2019)

Hemorheological and Glycemic Parameters and HDL Cholesterol for the Prediction of Cardiovascular Events
por: Cho, Sung Woo, et al.
Publicado: (2016)

CANHEART: Is HDL cholesterol a cardiovascular specific risk factor?
por: Hassan, Mohamed, et al.
Publicado: (2016)

HDL Cholesterol and Non-Cardiovascular Disease: A Narrative Review
por: Kjeldsen, Emilie W., et al.
Publicado: (2021)

Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting
por: Hasvold, Pål, et al.
Publicado: (2015)

HDL Cholesterol Story Is Dead: Long Live HDL!
por: Simha, Vinaya, et al.
Publicado: (2016)

Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis
por: Wang, Dianhui, et al.
Publicado: (2018)

Raising HDL cholesterol in women
por: Eapen, Danny J, et al.
Publicado: (2010)

Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres: Effects of HDL Particle Remodeling on Cholesterol Efflux
por: Navdaev, Alexei V., et al.
Publicado: (2020)

Examination of Data, Analytical Issues and Proposed Methods for Conducting Comparative Effectiveness Research Using “Real-World Data”
por: Alemayehu, Demissie, et al.
Publicado: (2011)

Artifactual measurement of low serum HDL-cholesterol due to paraproteinemia
por: van Gorselen, Edwin O. F., et al.
Publicado: (2010)

Corneal Clouding in a Young Woman With Low HDL Cholesterol
por: Koenig, Lisa R., et al.
Publicado: (2019)

Esterification of HDL-cholesterol is Decreased in Diabetes Mellitus and CAD and Enhanced Following Treatment with Statins
por: Bagheri, Babak, et al.
Publicado: (2018)

Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment
por: Yun, Yeo-Min
Publicado: (2023)

FSMP-11. TARGETING CHOLESTEROL HOMEOSTASIS DYSREGULATION FOR THE TREATMENT OF GLIOBLASTOMA
por: Han, Mingzhi
Publicado: (2021)

HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control
por: Denimal, Damien, et al.
Publicado: (2022)

Normal Non-HDL Cholesterol, Low Total Cholesterol, and HDL Cholesterol Levels in Sickle Cell Disease Patients in the Steady State: A Case-Control Study of Tema Metropolis
por: Ephraim, Richard K. D., et al.
Publicado: (2016)

Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy: Results of the ADVANCE study
por: Morton, Jamie, et al.
Publicado: (2012)

Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level
por: Paavola, Timo, et al.
Publicado: (2017)

Low HDL cholesterol is correlated to the acute ischemic stroke with diabetes mellitus
por: Luo, Yun, et al.
Publicado: (2014)

Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort study
por: Wang, Kun, et al.
Publicado: (2018)

Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer
por: Loosen, Sven H., et al.
Publicado: (2021)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2017)

HDL cholesterol is associated with PBMC expression of genes involved in HDL metabolism and atherogenesis
por: Dergunova, Liudmila V., et al.
Publicado: (2020)

High HDL-Cholesterol Paradox: SCARB1-LAG3-HDL Axis
por: Rodriguez, Annabelle
Publicado: (2021)

An Innovative Multipartner Research Program to Address Detection, Assessment and Treatment of Neonatal Infections in Low-resource Settings
por: Qazi, Shamim Ahmad, et al.
Publicado: (2013)

ASGR1 - a new target for lowering non-HDL cholesterol
por: Hassan, Mohamed, et al.
Publicado: (2016)

High-density lipoprotein cholesterol (HDL-C) in cardiovascular disease: effect of exercise training
por: Ahn, Nayoung, et al.
Publicado: (2016)

Non-HDL-cholesterol to HDL-cholesterol ratio is an independent risk factor for liver function tests abnormalities in geriatric population
por: An, Tianhui, et al.
Publicado: (2018)

Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults
por: Ward, Michael A., et al.
Publicado: (2010)

National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries
Publicado: (2020)

Multidrug-resistant Nontyphoidal Salmonella Hotspots as Targets for Vaccine Use in Management of Infections in Endemic Settings
por: Kariuki, Samuel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3jr57enkrj6h8unli39n3u4u3h